| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Neurology, Vol 50, Issue 6 1806-1813, Copyright © 1998 by American Academy of Neurology
ARTICLES |
S Vernino, J Adamski, TJ Kryzer, RD Fealey and VA Lennon
Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA.
BACKGROUND: Autoantibodies specific for the acetylcholine receptor (AChR) of skeletal muscle (containing the alpha1 subunit) impair neuromuscular transmission in myasthenia gravis (MG). AChRs mediating fast synaptic transmission through autonomic ganglia are structurally similar to muscle AChR, but contain the alpha3 subunit. We propose that ganglionic AChR autoimmunity may cause dysautonomia. OBJECTIVE: To test serum of patients with autonomic neuropathy for autoantibodies of neuronal ganglionic AChR specificity. METHODS: We developed an immunoprecipitation radioassay by complexing epibatidine (125I-labeled high affinity agonist) to a Triton X-100-solubilized AChR antigen from peripheral neuroblastoma membranes. Monoclonal rat immunoglobulins (IgG) specific for muscle or neuronal AChRs validated the assay's specificity. We tested serum from 52 healthy subjects, 12 patients with subacute autonomic neuropathy, and 248 patients with other neurologic disorders. RESULTS: Twelve patients had antibodies that bound unequivocally to ganglionic AChR. Five had subacute autonomic neuropathy, and three (of six tested) had Isaacs' syndrome; four of these eight had a carcinoma (lung, bladder, rectum, thyroid). The remaining four seropositive patients (two Lambert-Eaton syndrome, one dementia, one sensory neuronopathy) all had Ca2+ channel antibodies and three had small cell lung carcinoma. No healthy subject had ganglionic AChR antibodies, nor did 62 patients with MG and muscle AChR antibodies. CONCLUSION: Neuronal AChR antibodies are a novel serologic marker of neurologic autoimmunity. The pathogenicity of neuronal AChR autoantibodies in autonomic neuropathy, Isaacs' syndrome, or other neurologic disorders remains to be shown, as has been demonstrated for muscle AChR antibodies in MG. An autoimmune and potentially paraneoplastic etiology is implicated in seropositive patients.
This article has been cited by other articles:
|
|
 |
|
  J. LINDSTROM, J. LUO, and A. KURYATOV Myasthenia Gravis and the Tops and Bottoms of AChRs: Antigenic Structure of the MIR and Specific Immunosuppression of EAMG Using AChR Cytoplasmic Domains Ann. N.Y. Acad. Sci., June 1, 2008; 1132(1): 29 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. VERNINO Neuronal Acetylcholine Receptor Autoimmunity Ann. N.Y. Acad. Sci., June 1, 2008; 1132(1): 124 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Vernino, P. Sandroni, W. Singer, and P. A. Low Invited Article: Autonomic ganglia: Target and novel therapeutic tool Neurology, May 13, 2008; 70(20): 1926 - 1932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Modoni, M. Mirabella, F. Madia, T. Sanna, G. Lanza, P. A. Tonali, and G. Silvestri Chronic autoimmune autonomic neuropathy responsive to immunosuppressive therapy Neurology, January 9, 2007; 68(2): 161 - 162. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Schroeder, S. Vernino, A. L. Birkenfeld, J. Tank, K. Heusser, A. Lipp, T. Benter, C. Lindschau, R. Kettritz, F. C. Luft, et al. Plasma exchange for primary autoimmune autonomic failure. N. Engl. J. Med., October 13, 2005; 353(15): 1585 - 1590. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Llabres, F J Molina-Martinez, and F Miralles Dysphagia as the sole manifestation of myasthenia gravis J. Neurol. Neurosurg. Psychiatry, September 1, 2005; 76(9): 1297 - 1300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. I. Vinik, D. Anandacoomaraswamy, and J. Ullal Antibodies to Neuronal Structures: Innocent bystanders or neurotoxins? Diabetes Care, August 1, 2005; 28(8): 2067 - 2072. [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Obaid, M. E. Nelson, J. Lindstrom, and B. M. Salzberg Optical studies of nicotinic acetylcholine receptor subtypes in the guinea-pig enteric nervous system J. Exp. Biol., August 1, 2005; 208(15): 2981 - 3001. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Shibao, A. Gamboa, A. Diedrich, and I. Biaggioni Management of Hypertension in the Setting of Autonomic Failure: A Pathophysiological Approach Hypertension, April 1, 2005; 45(4): 469 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Vernino and V. A. Lennon Autoantibody Profiles and Neurological Correlations of Thymoma Clin. Cancer Res., November 1, 2004; 10(21): 7270 - 7275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. N. Komal Kumar, S. A. Patil, A. B. Taly, M. Nirmala, S. Sinha, and G. R. Arunodaya Effect of D-penicillamine on neuromuscular junction in patients with Wilson disease Neurology, September 14, 2004; 63(5): 935 - 936. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Vernino, L. G. Ermilov, L. Sha, J. H. Szurszewski, P. A. Low, and V. A. Lennon Passive Transfer of Autoimmune Autonomic Neuropathy to Mice J. Neurosci., August 11, 2004; 24(32): 7037 - 7042. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Qiu, X. Zhu, L. Zhang, Y. Mao, J. Zhang, P. Hao, G. Li, P. Lv, Z. Li, X. Sun, et al. Human Epithelial Cancers Secrete Immunoglobulin G with Unidentified Specificity to Promote Growth and Survival of Tumor Cells Cancer Res., October 1, 2003; 63(19): 6488 - 6495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Biaggioni Autoimmune Ganglionic Blockade. A Cause of Autonomic Failure. Focus on "Experimental Autoimmune Autonomic Neuropathy" J Neurophysiol, September 1, 2003; 90(3): 1377 - 1378. [Full Text] [PDF]
|
|
|
|
|
|
S. Vernino, P. A. Low, and V. A. Lennon Experimental Autoimmune Autonomic Neuropathy J Neurophysiol, September 1, 2003; 90(3): 2053 - 2059. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Novak, M.L. Freimer, J.T. Kissel, Z. Sahenk, I.M. Periquet, S.M. Nash, M.P. Collins, and J.R. Mendell Autonomic impairment in painful neuropathy Neurology, April 10, 2001; 56(7): 861 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Gahring, N. G. Carlson, E. L. Meyer, and S. W. Rogers Cutting Edge: Granzyme B Proteolysis of a Neuronal Glutamate Receptor Generates an Autoantigen and Is Modulated by Glycosylation J. Immunol., February 1, 2001; 166(3): 1433 - 1438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Vernino, P. A. Low, R. D. Fealey, J. D. Stewart, G. Farrugia, and V. A. Lennon Autoantibodies to Ganglionic Acetylcholine Receptors in Autoimmune Autonomic Neuropathies N. Engl. J. Med., September 21, 2000; 343(12): 847 - 855. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Vernino, R. G. Auger, A. M. Emslie-Smith, C. M. Harper, and V. A. Lennon Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability Neurology, October 1, 1999; 53(6): 1233 - 1233. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
